| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Biomarkers in toxicology and risk assessment: informing critical dose-response relationships.
|
Chem Res Toxicol
|
2007
|
2.53
|
|
2
|
Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver.
|
Toxicol Sci
|
2006
|
1.16
|
|
3
|
Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2009
|
1.11
|
|
4
|
Formaldehyde-induced histone modifications in vitro.
|
Chem Res Toxicol
|
2008
|
1.09
|
|
5
|
Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis.
|
Proteomics Clin Appl
|
2007
|
1.08
|
|
6
|
Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
|
Carcinogenesis
|
2002
|
1.02
|
|
7
|
Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2011
|
1.00
|
|
8
|
A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate.
|
Rapid Commun Mass Spectrom
|
2008
|
0.98
|
|
9
|
1,3-Butadiene: Biomarkers and application to risk assessment.
|
Chem Biol Interact
|
2010
|
0.97
|
|
10
|
NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.
|
J Mol Biol
|
2004
|
0.96
|
|
11
|
Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
|
Toxicol Sci
|
2010
|
0.95
|
|
12
|
Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
|
Chem Biol Interact
|
2006
|
0.94
|
|
13
|
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.
|
Exp Gerontol
|
2008
|
0.93
|
|
14
|
Low utilization of circulating glucose after food withdrawal in Snell dwarf mice.
|
J Biol Chem
|
2007
|
0.92
|
|
15
|
Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
|
Biochemistry
|
2007
|
0.91
|
|
16
|
Liquid chromatography electrospray ionization tandem mass spectrometry analysis method for simultaneous detection of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.
|
Toxicology
|
2009
|
0.89
|
|
17
|
Iminohydantoin lesion induced in DNA by peracids and other epoxidizing oxidants.
|
J Am Chem Soc
|
2009
|
0.88
|
|
18
|
Cooperative effects for CYP2E1 differ between styrene and its metabolites.
|
Xenobiotica
|
2013
|
0.88
|
|
19
|
Accurate quantitation of standard peptides used for quantitative proteomics.
|
Proteomics
|
2009
|
0.87
|
|
20
|
Future directions in butadiene risk assessment and the role of cross-species internal dosimetry.
|
Chem Biol Interact
|
2007
|
0.87
|
|
21
|
Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS.
|
Anal Bioanal Chem
|
2011
|
0.87
|
|
22
|
Comparison of three oxidative stress biomarkers in a sample of healthy adults.
|
Biomarkers
|
2009
|
0.86
|
|
23
|
Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
|
Chem Res Toxicol
|
2009
|
0.86
|
|
24
|
Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans.
|
J Nutr
|
2011
|
0.86
|
|
25
|
Profiling of ecdysteroids in complex biological samples using liquid chromatography/ion trap mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2006
|
0.84
|
|
26
|
CYP2E1 metabolism of styrene involves allostery.
|
Drug Metab Dispos
|
2012
|
0.84
|
|
27
|
A 2-iminohydantoin from the oxidation of guanine.
|
Chem Res Toxicol
|
2006
|
0.82
|
|
28
|
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.
|
Drug Metab Dispos
|
2013
|
0.81
|
|
29
|
Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.
|
Chem Biol Interact
|
2006
|
0.81
|
|
30
|
LC/MS/MS method for the quantitation of trans-2-hexenal-derived exocyclic 1,N(2)-propanodeoxyguanosine in DNA.
|
Chem Res Toxicol
|
2006
|
0.80
|
|
31
|
Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
|
Chem Biol Interact
|
2006
|
0.80
|
|
32
|
Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins.
|
Drug Metab Lett
|
2012
|
0.80
|
|
33
|
Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin.
|
Drug Metab Lett
|
2010
|
0.79
|
|
34
|
Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links.
|
PLoS One
|
2011
|
0.79
|
|
35
|
Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
|
Toxicol Lett
|
2013
|
0.79
|
|
36
|
Measurement of acylcarnitine substrate to product ratios specific to biotin-dependent carboxylases offers a combination of indicators of biotin status in humans.
|
J Nutr
|
2012
|
0.78
|
|
37
|
Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design.
|
J Nutr
|
2011
|
0.77
|
|
38
|
Identification and characterization of 2'-deoxyadenosine adducts formed by isoprene monoepoxides in vitro.
|
Chem Res Toxicol
|
2011
|
0.76
|
|
39
|
Detection and discrimination of DNA adducts differing in size, regiochemistry and functional group by nanopore sequencing.
|
Chem Res Toxicol
|
2020
|
0.75
|